Amiodarone: Difference between revisions

Line 25: Line 25:
*Bradycardia, hypotension
*Bradycardia, hypotension
*[[Prolonged QT]]
*[[Prolonged QT]]
*Thyrotoxicosis
**Between 5-20% of patients treated with amiodarone have thyrotoxicosis (higher in areas of iodine deficiency) <ref>Rosen's 8th Edition</ref>
***Iodine-induced hyperthyroidism
****It is thought that the iodine load may unmask hyperthyroidism in patients with multinodular goiter and subclinical Graves’ disease
***Drug-induced destructive thyroiditis
****More commonly, the cytotoxic effects of amiodarone destroy thyroid cells, resulting in a release of preformed hormone.


==See Also==
==See Also==

Revision as of 23:23, 20 February 2015

Adult Dosing

  • V-fib/pulseless V-tach
    • Loading dose = 300mg IV bolus followed by 150mg bolus prn
  • Stable V-tach or SVT
    • Loading dose = 150mg IV in 100mL D5W over 10min
      • Follow by infusion of 1mg/min x 6hr; 0.5mg/min thereafter

Contraindications

  • Iodine or shellfish allergy
  • Pregnancy

Indications

  • Ventricular and supraventricular arrhythmias
  • 1st line for pulseless V-tach/V-fib
  • Used for atrial arrhythmias in pts w/ decr EF

Mechanism of Action

  • Class III - Inhibits potassium channels
    • Impairs SA and AV node conduction
    • Decreases automaticity
    • Prolongs refractory period in accessory pathways
  • Also has class I & II properties

Adverse Drug Rxns

  • Bradycardia, hypotension
  • Prolonged QT
  • Thyrotoxicosis
    • Between 5-20% of patients treated with amiodarone have thyrotoxicosis (higher in areas of iodine deficiency) [1]
      • Iodine-induced hyperthyroidism
        • It is thought that the iodine load may unmask hyperthyroidism in patients with multinodular goiter and subclinical Graves’ disease
      • Drug-induced destructive thyroiditis
        • More commonly, the cytotoxic effects of amiodarone destroy thyroid cells, resulting in a release of preformed hormone.

See Also

  1. Rosen's 8th Edition